Cocaine use and post partum psychiatric symptoms

Area of Science:

• Perinatal mental health
• Substance use disorders
• Reproductive health

Background:

• Postpartum mental health is crucial for maternal and infant well-being.
• Substance use during pregnancy, including cocaine, poses risks to both mother and child.
• Understanding the interplay between mental health and substance use in postpartum women is essential for targeted interventions.

Purpose of the Study:

• To investigate the association between gestational cocaine use and mental health symptoms in postpartum women.
• To identify demographic and substance use characteristics associated with cocaine use in this population.

Main Methods:

• A cohort of 155 postpartum women was assessed.
• Cocaine use during pregnancy was determined via confidential interview or urine assay.
• Mental health symptoms were measured using a structured Psychiatric Symptom Index.

Main Results:

• 15% of women reported cocaine use during pregnancy.
• Cocaine users had lower education, higher parity, less pregnancy weight gain, and higher rates of cigarette, marijuana, and opiate use.
• High symptom frequencies were observed across depression, anxiety, cognitive disturbance, and anger, but no significant differences were found between cocaine users and non-users on the Psychiatric Symptom Index.

Conclusions:

• Gestational cocaine use was not significantly associated with increased mental health symptom severity in postpartum women.
• Cocaine-using postpartum women exhibited distinct demographic and polysubstance use profiles.
• Further research is needed to explore the complex relationship between perinatal substance use and mental health outcomes.